Clinical Trials Directory

Trials / Terminated

TerminatedNCT01178255

Efficacy and Safety of Homeopathy for Moderate Depression (Acute Phase)

Homeopathy for Depression: a Randomized, Partially Double-blind, Placebo Controlled, Four Armed Study DEP-HOM

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To assess the two components of individualized homeopathic treatment for acute depression, i.e., to investigate the specific effect of individualized Q-potencies versus placebo and to investigate the effect of different approaches to the homeopathic case history taking(defined in this study as case history taking type I and II).

Detailed description

Homeopathy is often sought by patients with depression. In classical homeopathy, the treatment consists of two main elements: the taking of the case history and the prescription of an individually selected homeopathic remedy. Homeopathic medicines are produced through sequential, agitated dilutions. A Q-Potency is prepared by grinding the raw material, followed by a process of consecutive 1:50.000 agitated dilutions. Previous data suggest that individualized homeopathic Q-potencies were non inferior to the antidepressant fluoxetine in a sample of patients with moderate to severe major depression. The question remains whether individualized homeopathic Q-potencies have a specific therapeutical effect in acute depression as this has not yet been investigated.

Conditions

Interventions

TypeNameDescription
DRUGhomeopathic q-potenciesindividualised homeopathic medicines
DRUGPlaceboplacebo
OTHERhomeopathic case history taking type Ione special homeopathic technique for case history taking
OTHERhomeopathic case history type IIanother type of homeopathic case history taking

Timeline

Start date
2010-08-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-08-10
Last updated
2012-07-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01178255. Inclusion in this directory is not an endorsement.